Skip to main content

Research and statistics

Skip to results
379 results that are All research and statistics, sorted by Updated (newest)
From UK Health Security Agency (UKHSA)
  • Analysis of data for statutory notifications of infectious diseases (NOIDs) in England and Wales in 2024.

  • Number of laboratory confirmed cases of measles in England.

  • Reports of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in hospital and community settings in England during the 2024 to 2025 season.

  • Notifications of infectious diseases (NOIDs) for the last 52 weeks.

  • UK quarterly data and commentary on coverage achieved by the UK childhood immunisation programme.

  • This report outlines the quality and methodology information (QMI) relevant to the HCAI accredited official statistics releases.

  • These 2 rapid reviews identify and summarise evidence on adverse health outcomes of chronic low-level exposure to hydrogen sulphide in adults and in children.

  • Findings from qualitative interviews among people newly diagnosed with HIV and those who were diagnosed late and living in England.

  • The latest information on mpox clade IIb cases in the UK. This page does not cover the current mpox clade I outbreak.

  • This rapid review aimed to identify and summarise the effectiveness of vaginal oestrogen in women who are experiencing peri menopause, menopause or post menopause to prevent primary urinary tract infections.

  • Voluntary surveillance of streptococcal bacteraemia in England.

  • This rapid review identified and summarised evidence of the accuracy of new diagnostic tests for Clostridioides difficile (C. difficile).

  • This annual report covers surgical site infection (SSI) data collected by NHS hospitals and independent sector NHS treatment centres.

  • Data tables and commentary for the Unlinked Anonymous Monitoring (UAM) Survey of infections and risk among people who inject drugs (PWID).

  • Number of laboratory confirmed cases of pertussis in England in 2024.

  • Incidence, treatment and prevention of tuberculosis (TB) in England using data up until the end of 2023.

  • Monthly counts of Escherichia coli (E.coli) bacteraemia by organisation and location of onset (from April 2019).

  • Monthly counts of meticillin-susceptible Staphylococcus aureus (MSSA) bacteraemia by organisation and location of onset (from April 2019).

  • Monthly counts of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by organisation and location of onset (from April 2019).

  • Monthly counts of Clostridioides difficile (C. difficile) infections by NHS organisation and prior trust exposure (from April 2019) in patients aged 2 years and over.